In a groundbreaking development, the U.S. Food and Drug Administration has conducted its first preliminary study on kratom, a botanical compound that has been the subject of much debate. The study’s findings suggest that kratom leaves, when consumed in capsule form, appear to be safe even at high doses.
This research marks a significant step in understanding the compound, which has been used for centuries in Southeast Asia. The FDA’s investigation aims to address the lack of scientific data surrounding kratom, which they had previously identified as a potential public health threat.
While the results are encouraging for capsule users, questions remain about the safety of kratom in other forms, particularly drinks and concentrates more commonly consumed in the U.S. These products typically contain higher levels of the compound and may pose different risks.
This study could have far-reaching implications for the regulation and perception of kratom in the United States.